全球骨生長刺激器市場規模、佔有率、成長分析，依應用（脊柱融合、頜面和牙科）、最終用戶（醫院和 ASC、專科診所）- 2024-2031 年行業預測

Global Bone Growth Stimulators Market Size, Share, Growth Analysis, By Application(Spinal Fusion, Maxillofacial & Dental), By End User(Hospitals & ASCs, Specialty Clinics) - Industry Forecast 2024-2031

出版日期: 2024年03月25日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年，全球骨骼生長刺激劑市場規模為19.3億美元，預計將從2023年的20.2億美元成長到2031年的29.7億美元，預測期間（2024-2031年）複合年成長率為4.9%。

骨生長刺激作為一種補充治療，已經相當受歡迎，特別是在骨癒合方面。骨刺激器通常用於治療未自然癒合的骨折。全球骨折和運動相關損傷的發生率不斷增加，刺激了對骨生長刺激劑的需求。根據國家脊髓損傷統計中心 (NSCISC) 的資料，美國每年每百萬人中約有 54 例脊髓損傷 (SCI)。根據國家生物技術資訊中心報告，全球每年有 25 萬至 50 萬人遭受脊髓損傷。骨科手術極大地受益於骨生長刺激技術和相關產品的進步。鑑於市場潛力，許多關於骨形態發生蛋白的臨床研究已經啟動。這些刺激器廣泛應用於各個醫療領域，包括脊椎融合、牙科、顎面手術、骨折修復等。由於骨關節炎和退化性骨疾病的日益流行，市場正在進一步擴大。此外，對富含血小板的血漿和骨形態發生蛋白的快速採用和需求預計將透過增強治療效果來促進市場成長。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名企業比較
2021 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率（%），2021年

主要公司簡介

Zimmer Biomet Holdings, Inc. (United States)
Stryker Corporation (United States)
Medtronic plc (Ireland)
Orthofix Medical Inc. (United States)
DJO Global, Inc. (United States)
Bioventus LLC (United States)
DePuy Synthes (a Johnson & Johnson Company) (United States)
Arthrex, Inc. (United States)
Smith & Nephew plc (United Kingdom)
Elizur Corporation (United States)
Isto Biologics (United States)
Ossatec Benelux BV (Netherlands)
Terumo Corporation (Japan)
RTI Surgical Holdings, Inc. (United States)
Bioventus LLC (United States)
Ember Therapeutics (United States)
Isto Biologics (United States)
DePuy Synthes Spine (United States)
Aetna Inc. (United States)
Ossatec Benelux BV (Netherlands)
BONESUPPORT AB (Sweden)
Regen Lab SA (Switzerland)

簡介目錄

Product Code: SQMIG35A2314

Global bone growth stimulators market size was valued at USD 1.93 billion in 2022 and is poised to grow from USD 2.02 billion in 2023 to USD 2.97 billion by 2031, at a CAGR of 4.9% during the forecast period (2024-2031).

Bone growth stimulation, a supplementary treatment, has gained considerable popularity, especially in the context of bone healing. Bone stimulators are commonly employed for fractures that have not healed naturally. The increasing incidence of bone fractures and sports-related injuries globally is fueling the demand for bone growth stimulators. According to data from the National Spinal Cord Injury Statistical Center (NSCISC), the United States sees approximately 54 cases of spinal cord injury (SCI) per million people each year. Globally, between 250,000 to 500,000 individuals suffer from spinal cord injuries annually, as reported by the National Center for Biotechnology Information. Orthopedic surgeries have greatly benefited from advancements in bone growth stimulation technology and related products. Given the market potential, numerous clinical studies on bone morphogenetic protein have been initiated. These stimulators find widespread use across various medical fields, including spinal fusion, dentistry, maxillofacial procedures, fracture repair, and others. The market is expanding further due to the growing prevalence of osteoarthritis and degenerative bone diseases. Additionally, the rapid adoption and demand for platelet-rich plasma and bone morphogenetic proteins are expected to contribute to market growth by enhancing healing outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the global bone growth stimulators market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bone Growth Stimulators Market Segmental Analysis

The global bone growth stimulators market is segmented based on product, application, end user and region. By product, the market is segmented into bone growth stimulation devices, bone morphogenetic proteins, platelet derived growth factor. By end user, the market is segmented into hospitals & ASCS, specialty clinics, home care. By application, the market is segmented into spinal fusion, maxillofacial & dental, nonunion & union bone fractures. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Bone Growth Stimulators Market

The increasing occurrence of orthopedic ailments, including fractures, delayed unions, non-unions, and fractures related to osteoporosis, serves as a major catalyst for the bone growth stimulators market. With the aging population expanding and the frequency of orthopedic conditions on the rise, there is a corresponding escalation in the demand for bone growth stimulators.

Restraints in the Global Bone Growth Stimulators Market

Although bone growth stimulators are generally deemed safe, there are potential side effects and risks linked to their utilization. These may encompass skin irritation, allergic reactions, and discomfort experienced during treatment. Worries regarding potential adverse effects could dissuade certain patients and healthcare practitioners from employing bone growth stimulators.

Market Trends of the Global Bone Growth Stimulators Market

Currently, the bone growth stimulators industry is experiencing notable shifts driven by several significant developments. One prominent trend is the growing demand for treatments that are more patient-friendly and less invasive. Bone growth stimulators are increasingly preferred by healthcare providers and patients alike for their capacity to offer a less invasive option compared to traditional surgical methods, thus promoting bone healing. This trend is particularly evident in the treatment of orthopedic conditions such as spinal fusion, fractures, and others.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Bone Growth Stimulators Market by Application

Market Overview
Spinal Fusion
Maxillofacial & Dental
Nonunion & Union Bone Fractures

Global Bone Growth Stimulators Market by End User

Market Overview
Hospitals & ASCs
Specialty Clinics
Home Care

Global Bone Growth Stimulators Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Zimmer Biomet Holdings, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix Medical Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DJO Global, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioventus LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DePuy Synthes (a Johnson & Johnson Company) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arthrex, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elizur Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Isto Biologics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ossatec Benelux B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RTI Surgical Holdings, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioventus LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ember Therapeutics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Isto Biologics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DePuy Synthes Spine (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aetna Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ossatec Benelux B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BONESUPPORT AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Regen Lab SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments